mRNA-4157,Pembrolizumab
Moderna,Merck
['thanks', 'moderna']
 thanks! sara is at #aacr23, where data from moderna's positive ph ii study with the mrna personalized cancer vaccine will be presented tomorrow. exciting times for #cancervaccines! 
Clinical-stage IO biotech on a mission to extend and improve the lives of patients. Directing the immune system against cancer in five phase II clinical trials.